H.R. 2407 118th Congress
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- Health
- Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
- Congress.gov ↗
Latest action, Dec 17, 2024: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-893, Part I.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
319 cosponsors
Sponsored by Rep. Arrington, Jodey C. [R-TX-19] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
181 D · 138 R
- Democrat
- Republican
- Independent
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
8 reports
8 reports
GRAIL, INC
ALEXANDER J. BECKLES, L.L.C.
8 reports
GRAIL, INC.
THE MCMANUS GROUP
8 reports
GRAIL, INC.
BALLARD SPAHR LLP
8 reports
7 reports
CARIS LIFE SCIENCES, INC.
SPLITOAK STRATEGIES LLC
7 reports
EXACT SCIENCES
THE DUBERSTEIN GROUP INC.
7 reports
GRAIL LLC
MILLER STRATEGIES, LLC
7 reports
GRAIL, INC.
AVENUE SOLUTIONS
7 reports
EXACT SCIENCES CORPORATION
ALPINE GROUP PARTNERS, LLC.
6 reports
IPSEN BIOPHARMACEUTICALS, INC.
RICCHETTI INCORPORATED
6 reports
All 25 of 39 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| CHRONIC CARE POLICY ALLIANCE | 8 | $1.0M | Q1 2023 | Q3 2024 | yes | |
| EXACT SCIENCES | 8 | $3.2M | Q1 2023 | Q3 2024 | yes | |
| GRAIL, INC | ALEXANDER J. BECKLES, L.L.C. | 8 | $0 | Q1 2023 | Q3 2024 | — |
| GRAIL, INC. | THE MCMANUS GROUP | 8 | $0 | Q1 2023 | Q3 2024 | yes |
| GRAIL, INC. | BALLARD SPAHR LLP | 8 | $0 | Q1 2023 | Q3 2024 | yes |
| INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS | 8 | $1.2M | Q1 2023 | Q3 2024 | yes | |
| AMERICAN LUNG ASSOCIATION | 7 | $710K | Q4 2023 | Q3 2024 | yes | |
| CARIS LIFE SCIENCES, INC. | SPLITOAK STRATEGIES LLC | 7 | $280K | Q4 2023 | Q3 2024 | yes |
| EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| GRAIL LLC | MILLER STRATEGIES, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| GRAIL, INC. | AVENUE SOLUTIONS | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN | 7 | $540K | Q4 2023 | Q3 2024 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 6 | $2.3M | Q4 2023 | Q3 2024 | yes | |
| EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| IPSEN BIOPHARMACEUTICALS, INC. | RICCHETTI INCORPORATED | 6 | $120K | Q4 2023 | Q3 2024 | yes |
| JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A) | 6 | $1.5M | Q4 2023 | Q3 2024 | yes | |
| NATIONAL MINORITY QUALITY FORUM ACTION NETWORK | INTEGRATED SOLUTIONS GROUP | 6 | $272K | Q4 2023 | Q3 2024 | yes |
| GRAIL, INC. | 5 | $3.1M | Q4 2023 | Q3 2024 | yes | |
| GRAIL, INC. | TODD STRATEGY GROUP | 5 | $0 | Q1 2023 | Q1 2024 | yes |
| GRAIL, LLC | WILLIAMS AND JENSEN, PLLC | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) | DYKEMA GOSSETT PLLC | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| CHRONIC CARE POLICY ALLIANCE | SIMS STRATEGIES, LLC | 4 | $0 | Q4 2023 | Q3 2024 | yes |
| EXACT SCIENCES CORPORATION | ARENTFOX SCHIFF LLP | 4 | $0 | Q1 2023 | Q3 2023 | yes |
| GRAIL, LLC | TIBER CREEK HEALTH STRATEGIES, INC. | 4 | $0 | Q1 2024 | Q3 2024 | — |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 3 | $5.5M | Q4 2024 | Q3 2024 | yes |